Cbdmd Inc Stock Price, News & Analysis

cbdMD (NYSE American: YCBD), a leading CBD company, has scheduled a conference call to discuss its Q3 FY2025 financial results for the period ending June 30, 2025. The call will take place on Thursday, August 14, 2025, at 4:20 p.m. Eastern Time.

Investors can access the call through multiple channels including USA/Canada (833-821-3524) and International (647-846-2919) dial-in numbers. A replay will be available with passcode 5327882, and the webcast replay will remain accessible through August 15, 2026, via the provided link.

cbdMD (NYSE American: YCBD) has announced the retail launch of its Herbal Oasis Social Tonics at select Total Wine locations in Charlotte and surrounding North Carolina areas. The hemp-derived THC seltzers, initially launched in late 2024, feature a unique blend of functional mushrooms, adaptogens, and nootropics including Lion's Mane, Reishi, Cordyceps, and Maitake.

The product line offers four flavors - Berry Fusion, Lemon Lift, Mango Bliss, and Tropical Twist - and is positioned as a low-calorie alternative to alcoholic beverages. Each drink is enhanced with L-theanine and B12, designed to provide calm energy and social clarity.

Herbal Oasis, a hemp-derived THC-infused social seltzer brand owned by cbdMD (YCBD), has announced a new distribution partnership with Beverage South to expand its presence in Georgia. This marks the company's fourth state expansion in two months, following launches in Alabama, Florida, and North Carolina.

The partnership strengthens Oasis's footprint in the Southeast region, aligning with their goal of becoming the leading THC seltzer brand. The THC beverage market is projected to grow by 50% in 2025, reaching $571 million in US sales according to Brightfield estimates. Oasis's products are infused with THC, CBG, and functional mushrooms, positioning themselves as an alcohol alternative focused on presence, clarity, and social connection.

cbdMD (NYSE: YCBD) reported Q2 fiscal 2025 results showing continued growth and improved financial performance. Net sales increased 8.6% to $4.7 million compared to $4.4 million in the prior year period. The company significantly narrowed its operating loss to $485,000 from $1.5 million year-over-year, while gross margin improved from 59% to 62%. Key developments include the completion of Series A Preferred Stock conversion, adding nearly $7 million to equity base and eliminating $6.7 million in dividend liability. The company executed an 8:1 reverse stock split, resulting in approximately 8.9 million common shares outstanding. cbdMD's Herbal Oasis brand expanded distribution into Alabama, Florida, and North Carolina, with all four flavors receiving medals at the 2025 High Spirits Awards. Direct-to-consumer sales represented 77% of total revenue at $3.6 million, while wholesale revenue grew to $1.1 million. The company ended the quarter with $1.8 million in cash and achieved compliance with NYSE American listing standards following the capital restructuring.

cbdMD, Inc. (NYSE American: YCBD), a leading CBD company, has announced it will host a conference call to discuss its second quarter fiscal year 2025 financial results for the period ending March 31, 2025. The conference call is scheduled for Thursday, May 15, 2025, at 4:20 p.m. Eastern Time. Participants can join via USA/Canada (833-821-3524) or International (647-846-2919) dial-in numbers. A replay will be available through dedicated phone lines and a webcast replay link will remain accessible until May 15, 2026.

Herbal Oasis, a hemp-derived THC-infused social seltzer brand owned by cbdMD (YCBD), has announced a new distribution agreement with Carolina Premium Beverage to serve Charlotte, NC and surrounding counties starting May 2025. This expansion marks the brand's entry into its third state in two months, following successful launches in Alabama and Florida.

The beverage brand, targeting sober-curious and health-conscious consumers, combines hemp-derived THC, CBG, and functional mushrooms to create an alcohol alternative. The partnership with Carolina Premium Beverage aims to accelerate market penetration in Charlotte, the company's home territory, while supporting its broader Southeast expansion strategy.

Herbal Oasis has achieved significant recognition at the 2025 High Spirits Awards, securing multiple medals for their hemp-infused beverages. Their products earned a Gold Medal for Mango Bliss, Silver Medals for Lemon Lift and Tropical Twist, and a Bronze Medal for Berry Fusion.

Launched in late 2024, the brand competes in the 'Other Infused Beverage Products' category, offering non-alcoholic alternatives combining hemp-derived THC, CBG, and functional mushrooms. The recognition comes just four months after their national launch.

The market outlook appears promising, with Euromonitor International projecting hemp-derived THC beverage sales to reach $4.1 billion by 2028. The company has begun distribution in Alabama, Florida, and North Carolina, with plans for expansion throughout spring and summer, while also offering nationwide delivery through their website.

cbdMD (YCBD) has announced two significant corporate actions effective May 6, 2025: the automatic conversion of its 8% Series A Cumulative Convertible Preferred Stock into Common Stock, and a one-for-eight reverse stock split.

The preferred stock conversion will convert each preferred share into thirteen common shares, eliminating approximately $6.7 million in accrued dividend liabilities and $4.0 million in perpetual annual obligations. The last trading day for preferred stock will be May 5, 2025.

Following both corporate actions, YCBD's outstanding common shares will consolidate from approximately 71.26 million to 8.91 million shares. The reverse split will be effective after market close on May 6, 2025, with post-split trading beginning May 7, 2025. The company will maintain its NYSE American listing under the YCBD symbol with a new CUSIP number.

cbdMD (NYSE: YCBD) announced shareholder approval for the automatic conversion of its Series A Preferred Stock into Common Stock at its April 10, 2025 annual meeting. The conversion will transform each preferred share into thirteen common shares, eliminating approximately $6.7 million in accrued dividend payments and $4 million in annual dividend obligations.

The company also secured shareholder approval for:

• Election of seven directors for the 2026 term
• Appointment of Cherry Bekaert LLP as independent auditor
• Authorization for a potential reverse stock split ranging from 1:3 to 1:10 within one year

CEO Ronan Kennedy stated this conversion will enhance their capital structure, enable reinvestment in growth initiatives, and support continued NYSE American listing requirements while removing barriers to strategic M&A activities.